Effect of Ranitidine on Hyper-IgE Recurrent Infection (Job's) Syndrome

Clinical trial NCT00527878 · TERMINATED

Trial details

NCT number: NCT00527878
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

JOB's Syndrome Hyper-IgE Recurrent Infection Syndrome Immune Deficiency

Start date: 2007-09-01
Primary completion: 2011-06-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.